Evidence map›Paper›PMID 31820256›Full record

ArticleAAPS PharmSciTech2019

Stable Immune Response Induced by Intradermal DNA Vaccination by a Novel Needleless Pyro-Drive Jet Injector.

Chinyang Chang, Jiao Sun, Hiroki Hayashi, Ayano Suzuki, Yuko Sakaguchi, Hiroshi Miyazaki, Tomoyuki Nishikawa, Hironori Nakagami, Kunihiko Yamashita, Yasufumi Kaneda

Open access · hybridAbstract read
In one paragraph

Article in AAPS PharmSciTech, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Chinyang ChangDepartment of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Jiao SunDepartment of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Hiroki HayashiDepartment of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Ayano SuzukiMedical Device Division, Daicel Corporation, R&D Headquarters, Minato-ku, Tokyo, Japan.
Yuko SakaguchiMedical Device Division, Daicel Corporation, R&D Headquarters, Minato-ku, Tokyo, Japan.
Hiroshi MiyazakiMedical Device Division, Daicel Corporation, R&D Headquarters, Minato-ku, Tokyo, Japan.
Tomoyuki NishikawaDepartment of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Hironori NakagamiDepartment of Health Development and Medicine, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Kunihiko YamashitaDepartment of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan. ku_yamashita@impulse.med.osaka-u.ac.jp.
Yasufumi KanedaDepartment of Device Application for Molecular Therapeutics, Osaka University Graduate School of Medicine, Suita-shi, Osaka, Japan.
Osaka University · JPDaicel (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

DNA vaccination can be applied to the treatment of various infectious diseases and cancers; however, technical difficulties have hindered the development of an effective delivery method. The efficacy of a DNA vaccine depends on optimal antigen expression by the injected plasmid DNA. The pyro-drive jet injector (PJI) is a novel system that allows for adjustment of injection depth and may, thus, provide a targeted delivery approach for various therapeutic or preventative compounds. Herein, we investigated its potential for use in delivering DNA vaccines. This study evaluated the optimal ignition powder dosage, as well as its delivery effectiveness in both rat and mouse models, while comparing the results of the PJI with that of a needle syringe delivery system. We found that the PJI effectively delivered plasmid DNA to intradermal regions in both rats and mice. Further, it efficiently transfected plasmid DNA directly into the nuclei, resulting in higher protein expression than that achieved via needle syringe injection. Moreover, results from animal ovalbumin (OVA) antigen induction models revealed that animals receiving OVA expression plasmids (pOVA) via PJI exhibited dose-dependent (10 μg, 60 μg, and 120 μg) production of anti-OVA antibodies; while only low titers (< 1/100) of OVA antibodies were detected when 120 μg of pOVA was injected via needle syringe. Thus, PJI is an effective, novel method for delivery of plasmid DNA into epidermal and dermal cells suggesting its promise as a tool for DNA vaccination.

Indexed as

Administration, CutaneousAnimalsFemaleInjectionsMiceMice, Inbred BALB CNeedlesRatsRats, Sprague-DawleyVaccinationVaccines, DNAVaccines, DNAanimal experimentsDNA vaccinejet injectorpyro-drivevaccine delivery

Identifiers

PMID31820256
PMCPMC6901418
OpenAlexW2994546495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.